tiprankstipranks
Trending News
More News >
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
US Market

Universe Pharmaceuticals (UPC) Income Statement

Compare
212 Followers

Universe Pharmaceuticals Income Statement

Last quarter (Q4 2025), Universe Pharmaceuticals's total revenue was $8.71M, a decrease of -37.10% from the same quarter last year. In Q4, Universe Pharmaceuticals's net income was $-387.30K. See Universe Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 17.86M$ 23.02M$ 32.31M$ 40.14M$ 47.98M
Gross Profit
$ 6.30M$ 6.07M$ 10.32M$ 21.89M$ 25.33M
Operating Expenses
$ 9.22M$ 14.09M$ 13.84M$ 28.91M$ 11.74M
Depreciation and Amortization
$ 517.43K$ 485.73K$ 508.79K$ 533.95K$ 446.88K
EBITDA
$ -2.92M$ -7.36M$ -3.18M$ -6.40M$ 14.20M
Operating Income
$ -2.92M$ -8.02M$ -3.53M$ -7.02M$ 13.59M
Other Income/Expenses
$ -756.14K$ -100.75K$ -413.77K$ -545.35K$ 57.51K
Pretax Income
$ -3.67M$ -8.12M$ -3.94M$ -7.98M$ 13.65M
Net Income
$ -3.67M$ -8.73M$ -6.16M$ -8.74M$ 11.32M
Per Share Metrics
Basic EPS
$ -1.06K$ -1.44K$ -1.04K$ -1.48K$ 2.15K
Diluted EPS
$ -1.06K$ -1.44K$ -1.04K$ -1.48K$ 2.15K
Weighted Average Shares Outstanding
3.48K 6.08K 5.92K 5.92K 5.27K
Weighted Average Shares Outstanding (Diluted)
3.48K 6.08K 5.92K 5.92K 5.27K
Currency in USD

Universe Pharmaceuticals Earnings and Revenue History